Literature DB >> 24767469

Features of breast cancer in developing countries, examples from North-Africa.

Marilys Corbex1, Sabiha Bouzbid2, Paolo Boffetta3.   

Abstract

Epidemiological features of breast cancer appear to be different in developing countries compared to Western countries, with notably large proportions of young patients, male patients and aggressive forms of the disease. Using North-Africa (Morocco, Algeria, Tunisia, Libya and Egypt) as an example, we document the magnitude and explore possible explanations for such patterns. Articles and reports published since the seventies were reviewed. Results show that breast cancer incidence in females is 2-4 times lower in North-Africa than in Western countries while incidence in males is similar. Consequently, the relative proportion of male breast cancer is high (≈2% of all breast cancers). Similarly, the incidence of aggressive forms of the disease, like inflammatory or triple negative breast cancer (in females), is not higher in North Africa than in Western countries, but their relative proportion in case series (up to 10% for inflammatory and 15-25% for triple negative) is significantly higher because of low incidence of other forms of the disease. In North Africa, the incidence among women aged 15-49 is lower than in Western countries, but the very low incidence among women aged more than 50, combined to the young age pyramid of North-Africa, makes the relative proportions of young patients substantially higher (50-60% versus 20% in France). Such epidemiological features result mainly from peculiar risk factor profiles, which are typical for many developing countries and include notably rapid changes in reproductive behaviours. These features have important implications for breast cancer control and treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Developing countries; Epidemiology; Inflammatory breast cancer; Male breast cancer; North-Africa; Triple negative breast cancer

Mesh:

Year:  2014        PMID: 24767469     DOI: 10.1016/j.ejca.2014.03.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  40 in total

Review 1.  Diagnostic performance of the automated breast volume scanner: a systematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions.

Authors:  Zheying Meng; Cui Chen; Yitong Zhu; Shuling Zhang; Cong Wei; Bin Hu; Li Yu; Bing Hu; E Shen
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

2.  Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018.

Authors:  Rajesh Sharma
Journal:  Breast Cancer Res Treat       Date:  2021-01-30       Impact factor: 4.872

3.  Effects of sulindac sulfide on proliferation and apoptosis of human breast cancer cell.

Authors:  He-Huan Sui; Yun-Jiang Zhou; Hu Wang; Li Li; Min Cao; Jia-Jun Huang
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

4.  Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.

Authors:  Jalila Rahoui; Abdelilah Laraqui; Yassir Sbitti; Nadia Touil; Azeddine Ibrahimi; Brahim Ghrab; Abderrahman Al Bouzidi; Driss Moussaoui Rahali; Mohamed Dehayni; Mohamed Ichou; Fatima Zaoui; Saad Mrani
Journal:  Med Oncol       Date:  2014-08-23       Impact factor: 3.064

5.  Breast cancer screening practices among first-generation immigrant muslim women.

Authors:  Memoona Hasnain; Usha Menon; Carol Estwing Ferrans; Laura Szalacha
Journal:  J Womens Health (Larchmt)       Date:  2014-05-27       Impact factor: 2.681

Review 6.  A Review on Breast Cancer Care in Africa.

Authors:  Eva J Kantelhardt; Gizaw Muluken; Getachew Sefonias; Ayele Wondimu; Hans Christoph Gebert; Susanne Unverzagt; Adamu Addissie
Journal:  Breast Care (Basel)       Date:  2015-12-21       Impact factor: 2.860

7.  Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.

Authors:  Dinesh Vyas; Nicolas Lopez-Hisijos; Sulakshana Gandhi; M El-Dakdouki; Marc D Basson; Mary F Walsh; X Huang; Arpita K Vyas; Lakshmi S Chaturvedi
Journal:  J Nanosci Nanotechnol       Date:  2015-09

8.  Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.

Authors:  Shengfeng Wang; Temidayo Ogundiran; Adeyinka Ademola; Oluwasola A Olayiwola; Adewunmi Adeoye; Adenike Sofoluwe; Imran Morhason-Bello; Stella Odedina; Imaria Agwai; Clement Adebamowo; Millicent Obajimi; Oladosu Ojengbede; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-04-20       Impact factor: 4.254

9.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

10.  Self-Efficacy for Coping with Breast Cancer in North-Eastern State of Peninsular Malaysia.

Authors:  Rodziah Ali; Nani Draman; Siti Suhaila Mohd Yusoff; Bachok Norsa'adah
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.